GSK-205667

Study Sponsor: GSK

Study Title

An open-label, single arm, repeat dose, multi-centre study to evaluate the use of a safety syringe for the subcutaneous administration of mepolizumab in subjects with severe eosinophilic asthma (Study 205667)

Medicine or Vaccine (generic name)

mepolizumab

Sponsor Identification Number

205667

Trial Registry Identification Number(#'s)

NCT03021304 2016-001831-10

Medical Condition

Asthma

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=205667

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03021304

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2016-001831-10

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The data for this study is available in CDISC format.

Date Added to this Site

May 2019